Items Tagged ‘News Tips and Features’


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s News Tips And Features News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.

July 12, 2018

Cyramza Improves Survival in Poor-Prognosis Liver Cancer

By Anonymous User anonymous_user_10987

Andrew X. Zhu, MD, PhD, director of Liver Cancer Research at Massachusetts General Hospital presented new data at the 2018 World Congress on Gastrointestinal Cancer (WCGC) demonstrating that Cyramza (ramucirumab) significantly improves survival in a subset of patients with hepatocellular carcinoma (HCC) who have high levels of the plasma protein α-fetoprotein (AFP), which is associated […]

View full entry

Tags: cyramza, hepatocellular cancer treatment, Liver Cancer, News Tips and Features, News Tips and Features Other


June 19, 2018

mFOLFIRINOX Found Superior to Gemzar for Treatment Surgically Resected Pancreatic Cancer

By Anonymous User anonymous_user_10987

The results of a recently presented clinical study at the American Society of Clinical Oncology meetings last week suggest that more aggressive chemotherapy treatment improves outcomes compared to single agent Gemzar (gemcitabine) chemotherapy which has been a standard treatment for over a decade. About Pancreatic Cancer Pancreatic cancer is one of the deadliest forms of […]

View full entry

Tags: Chemotherapy, gemzar, mFOLFIRINOX, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, treatment


FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

May 24, 2018

FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

By cancerconnect cancerconnect

Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. While Lucemyra may lessen the severity of withdrawal symptoms, it may […]

View full entry

Tags: News Tips and Features, News Tips and Features Other


Irritable Bowel Syndrome Tips for Symptom Management

May 16, 2018

Irritable Bowel Syndrome Tips for Symptom Management

By cancerconnect cancerconnect

Bloating is a common symptom in individuals with irritable bowel syndrome (IBS), particularly in women. Bloating may be the only symptom for some people with IBS and although not typically serious is quite discomforting. Irritable bowel syndrome is a disorder that affects the large intestine, or colon. Its symptoms include cramping, abdominal pain, bloating, constipation, […]

View full entry

Tags: Bloating, Irritable Bowel Syndrome, News Tips and Features, News Tips and Features Other, Tips for Symptom Management


Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

April 25, 2018

Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

By Anonymous User anonymous_user_10987

CancerConnect News: One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation that increases his or her cancer risk and many of these mutations could go undetected with the current screening approach, according to initial data from a statewide colorectal cancer screening study conducted at […]

View full entry

Tags: Colon Cancer, hereditary, lynch syndrome, News Tips and Features, News Tips and Features Other, ohio state-james cancer institute


First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study

April 18, 2018

First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study

By Anonymous User anonymous_user_10987

CancerConnect News: The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with pancreatic cancer will continue to enroll patients based on The Data Monitoring Committee first interim analyses and recommendation. About Pancreatic Cancer Pancreatic cancer is one of the deadliest forms of cancer. Each year, approximately 43,000 people […]

View full entry

Tags: AM0010, clinical trials, immunotherapy, Interleukin-10, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, pegilodecakin, Precision Cancer Medicine, treatment


Managing Side Effects From EGFR Inhibitors

April 10, 2018

Managing Side Effects From EGFR Inhibitors

By Anonymous User anonymous_user_10987

CancerConnect News: Epidermal Growth Factor Receptor (EGFR) inhibitor drugs are a type of precision cancer medicine commonly used to treat lung, colon, head and neck and other cancers that over express the EGFR.  There are several EGFR inhibitor drugs and these cause similar side effects. The EGFR pathway is a normal biologic pathway found in […]

View full entry

Tags: cetuximab, Colon Cancer, diarrhea, EGFR inhibitors, erbitux, Erlotinib, Gefitinib, Head and Neck Cancer, iressa, Lung Cancer, News Tips and Features, News Tips and Features Other


Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Colo-rectal Cancer

March 29, 2018

Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Colo-rectal Cancer

By cancerconnect cancerconnect

CancerConnect News: Clinical data from three ongoing larotrectinib (LOXO-101) clinical trials in patients whose tumors harbor tropomyosin receptor kinase (TRK) fusions demonstrating a 76 percent confirmed objective response rate (ORR) across tumor types, were published today in the New England Journal of Medicine after an initial summary presentation at the American Society of Clinical Oncology […]

View full entry

Tags: Colon Cancer, colorectal cancer, News Tips and Features, News Tips and Features Other, Rectal Cancer


CONDITIONS OF THE GI TRACT